Gynecologic bleeding revealing vaginal metastasis of renal cell carcinoma

od Benbrahim, Zineb, Chouaib, Ali, Mazeron, Renaud, Leger-Ravet, Marie Bénédicte, Lefort, Catherine, Lhommé, Catherine, El Mesbahi, Omar, Escudier, Bernard
Wydane 2013

Lymphocele and Ovarian Cancer: Risk Factors and Impact on Survival

od Gauthier, Tristan, Uzan, Catherine, Lefeuvre, Delphine, Kane, Aminata, Canlorbe, Geoffroy, Deschamps, Fredéric, Lhomme, Catherine, Pautier, Patricia, Morice, Philippe, Gouy, Sébastien
Wydane 2012

Prognostic Factors and Morbidities After Completion Surgery in Patients Undergoing Initial Chemoradiation Therapy for Locally Advanced Cervical Cancer

od Touboul, Cyril, Uzan, Catherine, Mauguen, Audrey, Gouy, Sebastien, Rey, Annie, Pautier, Patricia, Lhommé, Catherine, Duvillard, Pierre, Haie-Meder, Christine, Morice, Philippe
Wydane 2010

Prognosis and Prognostic Factors of the Micropapillary Pattern in Patients Treated for Stage II and III Serous Borderline Tumors of the Ovary

od Uzan, Catherine, Kane, Aminata, Rey, Annie, Gouy, Sebastien, Camatte, Sophie, Pautier, Patricia, Lhommé, Catherine, Haie-Meder, Christine, Duvillard, Pierre, Morice, Philippe
Wydane 2011

Kidney Diseases Associated With Anti-Vascular Endothelial Growth Factor (VEGF): An 8-year Observational Study at a Single Center

od Izzedine, Hassan, Escudier, Bernard, Lhomme, Catherine, Pautier, Patricia, Rouvier, Philippe, Gueutin, Victor, Baumelou, Alain, Derosa, Lisa, Bahleda, Rastilav, Hollebecque, Antoine, Sahali, Djillali, Soria, Jean Charles
Wydane w Medicine (Baltimore) (2014)

Optimizing Local Control in High‐Grade Uterine Sarcoma: Adjuvant Vaginal Vault Brachytherapy as Part of a Multimodal Treatment

od Annede, Pierre, Gouy, Sébastien, Mazeron, Renaud, Bentivegna, Enrica, Maroun, Pierre, Petit, Claire, Dumas, Isabelle, Leary, Alexandra, Genestie, Catherine, Lhommé, Catherine, Deutsch, Eric, Morice, Philippe, Pautier, Patricia, Haie‐Meder, Christine, Chargari, Cyrus
Wydane w Oncologist (2017)

Safety of bevacizumab in clinical practice for recurrent ovarian cancer: A retrospective cohort study

od SELLE, FRÉDÉRIC, EMILE, GEORGE, PAUTIER, PATRICIA, ASMANE, IRÈNE, SOARES, DANIELE G., KHALIL, AHMED, ALEXANDRE, JEROME, LHOMMÉ, CATHERINE, RAY-COQUARD, ISABELLE, LOTZ, JEAN-PIERRE, GOLDWASSER, FRANÇOIS, TAZI, YOUSSEF, HEUDEL, PIERRE, PUJADE-LAURAINE, ERIC, GOUY, SÉBASTIEN, TREDAN, OLIVIER, BARBAZA, MARIE O., ADY-VAGO, NORA, DUBOT, CORALINE
Wydane w Oncol Lett (2016)

Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers

od Cottu, Paul H., Bonneterre, Jacques, Varga, Andrea, Campone, Mario, Leary, Alexandra, Floquet, Anne, Berton-Rigaud, Dominique, Sablin, Marie-Paule, Lesoin, Anne, Rezai, Keyvan, Lokiec, François M., Lhomme, Catherine, Bosq, Jacques, Bexon, Alice S., Gilles, Erard M., Proniuk, Stefan, Dieras, Veronique, Jackson, David M., Zukiwski, Alexander, Italiano, Antoine
Wydane w PLoS One (2018)